https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-832006-06-13 00:00:002019-02-15 09:23:48Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-11 / Zhonghua Yi Xue Za Zhi 2006 Apr;86(14):943-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-11 / Zhonghua Yi Xue Za Zhi 2006 Apr;86(14):943-62006-04-11 00:00:002019-02-15 09:23:49[Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3709-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3709-142005-11-01 00:00:002019-02-15 09:23:49Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-01 / J. Immunother. 2005 Jul-Aug;28(4):332-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-01 / J. Immunother. 2005 Jul-Aug;28(4):332-422005-07-01 00:00:002019-02-15 09:23:50Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-01 / J. Gastrointest. Surg. 2004 Feb;8(2):175-81; discussion 181-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-01 / J. Gastrointest. Surg. 2004 Feb;8(2):175-81; discussion 181-22004-02-01 00:00:002019-02-15 09:23:51Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-03-01 / Int. J. Oncol. 2003 Mar;22(3):651-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-03-01 / Int. J. Oncol. 2003 Mar;22(3):651-62003-03-01 00:00:002019-02-15 09:23:52In vivo induction of dendritic cell-mediated cytotoxicity against allogeneic pancreatic carcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-08-02 / Dtsch. Med. Wochenschr. 2002 Aug;127(31-32):1660
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-08-02 / Dtsch. Med. Wochenschr. 2002 Aug;127(31-32):16602002-08-02 00:00:002002-08-02 00:00:00[Is total body hyperthermia plus chemotherapy useful in pancreas carcinoma?]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-62002-01-01 00:00:002019-02-15 08:52:35The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Cancer Res. 2001 Sep;61(17):6445-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Cancer Res. 2001 Sep;61(17):6445-502001-09-01 00:00:002019-02-15 09:23:53Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-08-01 / Int J Colorectal Dis 2000 Aug;15(4):197-205
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-08-01 / Int J Colorectal Dis 2000 Aug;15(4):197-2052000-08-01 00:00:002019-02-15 09:23:54Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients
